Related Experiment Video
Updated: Jun 25, 2026
06:32
Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
Respiratory infections in immunocompromised patients
Marcelo Corti1, Domingo Palmero, Kumiko Eiguchi
1Infectious Diseases Hospital F. J. Muñiz, Buenos Aires, Argentina. marcelocorti@fibertelcom.ar
Current Opinion in Pulmonary Medicine
|March 12, 2009
Summary
Pulmonary infections pose a significant risk to immunosuppressed patients. Strategies like prophylaxis, rapid diagnostics, and new drug development are crucial for managing these infections and combating antimicrobial resistance.
Area of Science:
- Infectious Diseases
- Immunology
- Pulmonology
Background:
- Immunosuppressive states and therapies are increasingly prevalent in clinical practice.
- Pulmonary infections represent a major threat to the well-being of immunosuppressed individuals.
Purpose of the Study:
- To review recent advances and trends in bacterial, fungal, viral, and parasitic pulmonary infections affecting immunosuppressed patients.
- To highlight the growing challenge posed by multidrug-resistant organisms and opportunistic pathogens.
Main Methods:
- Review of current literature on pulmonary infections in immunosuppressed populations.
- Analysis of trends in pathogen prevalence and treatment strategies.
Main Results:
- Increasing incidence of infections caused by multidrug-resistant bacteria and opportunistic pathogens (e.g., environmental mycobacteria, Strongyloides stercoralis, Rhodococcus equi).
- Rise in infections linked to human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and potent immunosuppressive therapies for transplants, cancer, and systemic diseases.
- Limited development of novel antibiotics necessitates focus on prevention and diagnostics.
Conclusions:
- Effective management requires adequate prophylaxis, high clinical suspicion, and comprehensive microbiological and molecular investigations.
- Treatment should be guided by drug susceptibility testing to combat antimicrobial resistance.
- Development of new antimicrobial agents is essential to address the evolving landscape of pulmonary infections in immunocompromised patients.
Related Concept Videos
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...